Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (61-70 of 431) with videos related to

Pageof 44
Sort By:
Current Vascular Pharmacology|December 10, 2021
Cilofexor for the Treatment of Nonalcoholic SteatohepatitisStergios A Polyzos, Konstantinos Xanthopoulos, Jannis Kountouras
Current Medicinal Chemistry|January 9, 2023
Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic SteatohepatitisStergios A Polyzos, Antonis Goulas, Paraskevi Papaioannidou
Endocrine|July 22, 2017
The intriguing connections of leptin to hyperparathyroidismStergios A Polyzos, Leonidas Duntas, Jens Bollerslev
Current Obesity Reports|February 18, 2026
Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Alessandro Mantovani, Giovanni Targher
Medical Hypotheses|January 24, 2009
Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathwaysStergios A Polyzos, Jannis Kountouras, Christos Zavos
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 17, 2010
Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras, Christos Zavos
Gastroenterology|August 18, 2018
Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel DiseaseJannis Kountouras, Stergios A Polyzos, Georgia Deretzi
Metabolism: Clinical and Experimental|May 24, 2019
Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?Stergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Journal of Personalized Medicine|July 27, 2022
Combination Therapies for Nonalcoholic Fatty Liver DiseaseEvangelia S Makri, Eleftheria Makri, Stergios A Polyzos
The Journal of Clinical Endocrinology and Metabolism|September 8, 2016
Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic AcidPolyzois Makras, Stergios A Polyzos, Athanasios D Anastasilakis
Pageof 44

Showing results (61-70 of 431) with videos related to

Sort By:
Pageof 44
Current Vascular Pharmacology|December 10, 2021
Cilofexor for the Treatment of Nonalcoholic SteatohepatitisStergios A Polyzos, Konstantinos Xanthopoulos, Jannis Kountouras
Current Medicinal Chemistry|January 9, 2023
Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic SteatohepatitisStergios A Polyzos, Antonis Goulas, Paraskevi Papaioannidou
Endocrine|July 22, 2017
The intriguing connections of leptin to hyperparathyroidismStergios A Polyzos, Leonidas Duntas, Jens Bollerslev
Current Obesity Reports|February 18, 2026
Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Alessandro Mantovani, Giovanni Targher
Medical Hypotheses|January 24, 2009
Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathwaysStergios A Polyzos, Jannis Kountouras, Christos Zavos
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 17, 2010
Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitisStergios A Polyzos, Jannis Kountouras, Christos Zavos
Gastroenterology|August 18, 2018
Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel DiseaseJannis Kountouras, Stergios A Polyzos, Georgia Deretzi
Metabolism: Clinical and Experimental|May 24, 2019
Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?Stergios A Polyzos, Jannis Kountouras, Christos S Mantzoros
Journal of Personalized Medicine|July 27, 2022
Combination Therapies for Nonalcoholic Fatty Liver DiseaseEvangelia S Makri, Eleftheria Makri, Stergios A Polyzos
The Journal of Clinical Endocrinology and Metabolism|September 8, 2016
Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic AcidPolyzois Makras, Stergios A Polyzos, Athanasios D Anastasilakis
Pageof 44